Summary: Millions of Americans are approaching a crucial but often overlooked window to reassess their Medicare coverage, a ...

Donald Trump's move to cut drug prices in America can potentially turn out to be a $35 billion additional cost to the federal ...

Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, will agree to sell their drugs to Medicare at a lower “most ...

Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan ...

WASHINGTON (AP) — President Donald Trump is once more targeting former President Barack Obama’s signature health care law, ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in certain cases, officials said.

President Donald Trump has long pushed to cut the price of GLP-1 medications, often expressing frustration about the high ...

US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices ...

Australians are being bombarded with tens of thousands of fake emails impersonating Centrelink and Services Australia in one ...

Uncertainty about federal food assistance and health-care subsidies is dominating much of the public's attention. But two other deeply concerning developments are underway, quietly hurting many ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.